HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration.

AbstractBACKGROUND:
Malignant melanoma cells are known to have altered expression of growth factors compared with normal human melanocytes. These changes most likely favour tumour growth and progression, and influence tumour environment. The induction of transforming growth factor beta1, 2 and 3 as well as BMP4 and BMP7 expression in malignant melanoma has been reported before, whereas the expression of an important modulator of these molecules, connective tissue growth factor (CTGF), has not been investigated in melanomas until now.
METHODS:
Expression of CTGF was analysed in melanoma cell lines and tissue samples by qRT-PCR and immunohistochemistry. To determine the regulation of CTGF expression in malignant melanoma, specific siRNA was used. Additionally, migration, invasion and attachment assays were carried out.
RESULTS:
We were able to demonstrate that CTGF expression is upregulated in nine melanoma cell lines and in primary and metastatic melanoma in situ. The transcription factor HIF-1α was revealed as a positive regulator for CTGF expression. Melanoma cells, in which CTGF expression is diminished, show a strong reduction of migratory and invasive properties when compared with controls. Further, treatment of normal human epidermal melanocytes with recombinant CTGF leads to an increase of migratory and invasive behaviour of these cells.
CONCLUSION:
These results suggest that CTGF promotes melanoma cell invasion and migration and, therefore, has an important role in the progression of malignant melanoma.
AuthorsS Braig, S Wallner, B Junglas, R Fuchshofer, A-K Bosserhoff
JournalBritish journal of cancer (Br J Cancer) Vol. 105 Issue 2 Pg. 231-8 (Jul 12 2011) ISSN: 1532-1827 [Electronic] England
PMID21673687 (Publication Type: Journal Article)
Chemical References
  • BAMBI protein, human
  • BMP7 protein, human
  • Bone Morphogenetic Protein 7
  • CCN2 protein, human
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Membrane Proteins
  • RNA, Small Interfering
  • Connective Tissue Growth Factor
Topics
  • Bone Morphogenetic Protein 7 (genetics, metabolism)
  • Cell Line, Tumor
  • Cell Movement (genetics)
  • Cells, Cultured
  • Connective Tissue Growth Factor (antagonists & inhibitors, genetics, pharmacology, physiology)
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical
  • Gene Expression Regulation, Neoplastic (drug effects, physiology)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism, physiology)
  • Melanocytes (drug effects, metabolism)
  • Melanoma (genetics, pathology)
  • Membrane Proteins (genetics, metabolism)
  • Neoplasm Invasiveness
  • RNA, Small Interfering (pharmacology)
  • Skin Neoplasms (genetics, pathology)
  • Up-Regulation (drug effects, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: